Stockwatch: Lax Approval Requirements Yield Blockbusters That Don’t Work

How Sarepta And Biogen Are Following The Actimmune Playbook

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.